ES548303A0 - Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida. - Google Patents

Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.

Info

Publication number
ES548303A0
ES548303A0 ES548303A ES548303A ES548303A0 ES 548303 A0 ES548303 A0 ES 548303A0 ES 548303 A ES548303 A ES 548303A ES 548303 A ES548303 A ES 548303A ES 548303 A0 ES548303 A0 ES 548303A0
Authority
ES
Spain
Prior art keywords
carboxamide
ribofuranosil
triazol
preparing
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES548303A
Other languages
English (en)
Other versions
ES8704962A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viratek Inc
Original Assignee
Viratek Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24673430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES548303(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Viratek Inc filed Critical Viratek Inc
Publication of ES548303A0 publication Critical patent/ES548303A0/es
Publication of ES8704962A1 publication Critical patent/ES8704962A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ES548303A 1984-10-29 1985-10-29 Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida. Expired ES8704962A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66625284A 1984-10-29 1984-10-29

Publications (2)

Publication Number Publication Date
ES548303A0 true ES548303A0 (es) 1987-04-16
ES8704962A1 ES8704962A1 (es) 1987-04-16

Family

ID=24673430

Family Applications (1)

Application Number Title Priority Date Filing Date
ES548303A Expired ES8704962A1 (es) 1984-10-29 1985-10-29 Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.

Country Status (19)

Country Link
EP (3) EP0181050A3 (es)
JP (1) JPH0713019B2 (es)
KR (1) KR860003018A (es)
AT (1) ATE204173T1 (es)
AU (1) AU584333B2 (es)
BE (1) BE902199A (es)
CA (1) CA1261265A (es)
DD (1) DD261094A5 (es)
DE (3) DE3588232T2 (es)
ES (1) ES8704962A1 (es)
FR (1) FR2572286B1 (es)
GB (1) GB2166050B (es)
HK (1) HK1010985A1 (es)
LU (1) LU85854A1 (es)
NL (1) NL300083I1 (es)
NZ (1) NZ212510A (es)
PH (1) PH22534A (es)
PT (1) PT81387B (es)
ZA (1) ZA858237B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650377T2 (de) * 1985-12-23 1996-02-22 Hutchinson Fred Cancer Res Regulierung der retroviralen replikation, infektion und pathogenese.
JP2792246B2 (ja) * 1991-01-31 1998-09-03 信越半導体株式会社 単結晶棒クランプ位置決め治具及びこれを用いた単結晶棒クランプ位置決め方法
CA2357735A1 (en) * 1999-01-29 2000-08-03 Icn Pharmaceuticals, Inc. Modulation of immune response by ribavirin
US6720000B2 (en) 2001-03-19 2004-04-13 Three Rivers Pharmaceutical, Llc Process for producing wet ribavirin pellets
US7132453B2 (en) * 2002-03-15 2006-11-07 Vanderbilt University Method of using prostacyclin to treat respiratory syncytial virus infections
US7538094B2 (en) 2002-09-19 2009-05-26 Three Rivers Pharmacueticals, Llc Composition containing ribavirin and use thereof
EP2959891A1 (en) 2014-06-23 2015-12-30 Sanovel Ilac Sanayi ve Ticaret A.S. Modified release pharmaceutical compositions of sofosbuvir and ribavirin
US20170151272A1 (en) 2014-06-23 2017-06-01 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A novel pharmaceutical composition of sofosbuvir and ribavirin
EA201692507A1 (ru) 2014-06-23 2017-04-28 Сановель Илач Санайи Ве Тиджарет А.Ш. Фармацевтические комбинации софосбувира и рибавирина

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
US3798209A (en) * 1971-06-01 1974-03-19 Icn Pharmaceuticals 1,2,4-triazole nucleosides
US3927216A (en) * 1971-06-01 1975-12-16 Icn Pharmaceuticals 1,2,4-Triazol E-3-carboxamides for inhibiting virus infections
AR205339A1 (es) * 1973-03-12 1976-04-30 Icn Pharmaceuticals Sintesis de 1,2,4-triazolo-3-carboxamidas utiles como agentes antivirales
WO1983003383A1 (en) * 1982-03-29 1983-10-13 Liposome Co Inc Stable plurilamellar vesicles

Also Published As

Publication number Publication date
CA1261265A (en) 1989-09-26
ZA858237B (en) 1988-02-24
JPS61109723A (ja) 1986-05-28
EP0643970A2 (en) 1995-03-22
EP0383361A3 (en) 1993-06-16
DE10299005I2 (de) 2004-07-01
GB2166050A (en) 1986-04-30
NL300083I1 (nl) 2002-05-01
DE3588232D1 (de) 2001-09-20
HK1010985A1 (en) 1999-07-02
GB2166050B (en) 1989-08-16
PT81387A (en) 1985-11-01
ATE204173T1 (de) 2001-09-15
BE902199A (fr) 1985-07-31
FR2572286B1 (fr) 1990-03-23
EP0383361A2 (en) 1990-08-22
EP0181050A3 (en) 1987-10-21
DE3588232T2 (de) 2002-06-13
AU4180785A (en) 1986-05-08
PT81387B (pt) 1987-11-11
GB8509689D0 (en) 1985-05-22
ES8704962A1 (es) 1987-04-16
LU85854A1 (fr) 1985-12-16
NZ212510A (en) 1989-04-26
FR2572286A1 (fr) 1986-05-02
EP0643970A3 (en) 1997-07-09
DE10299005I1 (de) 2002-05-08
PH22534A (en) 1988-10-17
EP0181050A2 (en) 1986-05-14
DD261094A5 (de) 1988-10-19
AU584333B2 (en) 1989-05-25
KR860003018A (ko) 1986-05-19
DE181050T1 (de) 1986-12-18
JPH0713019B2 (ja) 1995-02-15
EP0643970B1 (en) 2001-08-16

Similar Documents

Publication Publication Date Title
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
DE69200675D1 (de) Verwendung von Droloxifen bei der Behandlung von Knochenerkrankungen.
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
BR8502395A (pt) Processo para a preparacao de 1-heteroaril-4-aril-pirazolin-5-onas,composicoes microbicidas,processos para o combate de microbios e para a preparacao de composicoes e utilizacao
ES548303A0 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
ES2038650T3 (es) Procedimiento para preparar una composicion farmaceutica que comprende 3'-desoxitimidin-2'-eno-(3'-desoxi-2',3'-dideshidrotimidina) para tratar pacientes infectados con retrovirus.
ES2104142T3 (es) Aminociclohexilamidas para utilizacion antirritmica y anestesica.
NO893062D0 (no) Anvendelse av isokinolinforbindelser, saerlig i inhalasjonspreparater.
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
BR8300217A (pt) Composicoes herbicidas,processos para o combate de ervas daninhas e para a preparacao de composicoes
DK664188D0 (da) Butylhydroxyanisoler til behandling af retrovirale sygdomme
DK406589A (da) Middel til behandling af maligne tumorer, indeholdende 8-chloradenosin-3',5'-cyclisk phosphat, 8-aminoacenosin-3',5'-cyclisk phosphat
EP0149475A3 (en) Medicaments for the treatment and prevention of liver damage
ES511134A0 (es) "procedimiento de preparacion de nuevos derivados de la hidrazina, utiles como fungicidas y bactericidas".
ES516605A0 (es) "procedimiento para la produccion o tratamiento de ferrocromo".
NO993997L (no) Anvendelse av 9,10-sekokolesta-5,7,10(19)-trien-1-3-diol, eller alfakalsidol
BR8300715A (pt) Composicoes herbicidas, processos para o combate seletivo de ervas daninhas e para a preparacao de composicoes
UA22189A (uk) Іі-кабетоксифеhілакоhітімід, який виявляє активhість відhосhо вірусу везикулярhого стоматиту та вірусу простого герпесу
UA23352A (uk) beta- D- ГЛЮКОЗАМОHІЙHА СІЛЬ alРha-БРОМІЗОВАЛЕРІАHОВОЇ КИСЛОТИ, ЯКА МАЄ ПРОТИВІРУСHУ АКТИВHІСТЬ ВІДHОСHО ВІРУСУ ВЕЗИКУЛЯРHОГО СТОМАТИТУ, ВІРУСУ ПРОСТОГО ГЕРПЕСУ ТА КОРОHАВІРУСУ
IT8522576A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori, muscolari e articolari.
IS3304A7 (is) Aðferð til framleiðslu, notkun og samsetning efnablöndu til meðhöndlunar sóriasis, gigtar eða andarteppusjúkdóma.
ES548211A0 (es) Un procedimiento para preparar sal amonica de 1b-d-ribofuranosil-1,2,4-triazol-3-carboxamida -2'-3'-fosfato ciclico.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20070124